NVIV
-
Hospitals
InVivo Therapeutics Announces Approval for INSPIRE Pivotal Probable Benefit Clinical Study of the Neuro-Spinal Scaffold™
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) announced that it has received approval of a protocol amendment from the U.S. Food…
Read More » -
Neuro
InVivo Therapeutics Receives Notice of Allowance on Patent Covering Broader Compositions for Neuro-Spinal Scaffold and Neuro-Spinal Scaffold Plus Stem Cells
CAMBRIDGE, Mass. (June 22, 2015) – InVivo Therapeutics Holdings Corp. (NVIV) today announced that it has received a Notice of Allowance…
Read More » -
Spine
InVivo Therapeutics Announces James Guest, M.D., Ph.D., Has Joined Scientific Advisory Board
InVivo Therapeutics Holdings Corp. (NVIV) today announced that James Guest, M.D., Ph.D., has joined its Scientific Advisory Board. Dr. Guest is…
Read More » -
Financial
InVivo Therapeutics Reports 2015 First Quarter Financial Results and Business Update
CAMBRIDGE, Mass.–(BUSINESS WIRE)–InVivo Therapeutics Holdings Corp. (NVIV) today reported financial results for the quarter ended March 31, 2015. Mark Perrin, the…
Read More »